Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00628771 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
A Phase 4 study of HIV Infections and Pregnancy, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,233
- Enrollment target
- 3
- Study locations
NCT00628771: Completed Phase 4 study of HIV Infections and Pregnancy, sponsored by Yale University.
NCT00628771 is a Phase 4 study of HIV Infections and Pregnancy that has completed, run by Yale University. The registered enrollment target is 1,233 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (178% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00628771, a Phase 4 study of HIV Infections and Pregnancy, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,233 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropolitan area.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL CenteringPregnancy Plus (CP+)
Study Locations (3)
Connecticut
- Yale University School of PUblic Health - New Haven
Massachusetts
- Centering Healthcare Institute - Boston
New York
- Clinical Directors Network - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,233 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 4 |
What the finished NCT00628771 record still lists
NCT00628771 is an interventional study that assigns participants to a tested intervention. Its 1,233 participants enrollment target places it among the larger protocols in the corpus, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (178% higher).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00628771 reports a single indexed study location in Connecticut, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT00628771 about?
NCT00628771 is a clinical study titled "Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women". This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropoli...
What is the current status of trial NCT00628771?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,233 participants. The study started on 2008-06. Estimated completion is 2012-09.
What conditions does trial NCT00628771 study?
This clinical trial studies the following conditions: HIV Infections, Pregnancy, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT00628771?
The interventions under investigation include: Usual care (BEHAVIORAL), CenteringPregnancy Plus (CP+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00628771?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00628771 being conducted?
This trial has 3 study locations across Connecticut, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00628771's enrollment target sits among peer trials
1,233 20th of 542 higher than 523 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accelerated ART Initiation for PWHIV Who Are Out of Care
RECRUITING · Phase 4
-
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
RECRUITING · Phase 4
-
PrEP Intervention for People Who Inject Substances and Use Methamphetamine
RECRUITING · Phase 4
-
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
COMPLETED · Phase 4
-
"The Once A Day Protease Inhibitor Regimens"
COMPLETED · Phase 4
-
Buprenorphine and Integrated HIV Care
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia